# Commission Decision of 20 December 2011 amending Decision 2002/364/EC on common technical specifications for in vitro diagnostic medical devices (notified under document C(2011) 9398) (Text with EEA relevance) (2011/869/EU), Division 1: The following section is added at the end of Section 3 of the Annex to Decision 2002/364/EC:

Extent: E+W+S+N.I.

‘3.7.
CTS for Variant Creutzfeldt-Jakob disease (vCJD) assays for blood screening
CTS for Variant Creutzfeldt-Jakob disease (vCJD) assays for blood screening are set out in Table 11’

---
Source: https://www.legislation.gov.uk/eudn/2011/869/annex/division/1 (the official version)
Page: https://openlegislation.uk/eu-decision-2011-869/annex/division-1
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.